Wheeler Bio Launches New Website Reflecting Expansion of Capabilities, Clients Served, and a Commitment to High-Science, High-Touch Biologics Manufacturing

▤ Summary

Wheeler Bio launched a redesigned website that highlights its expanded biologics development and manufacturing capabilities. The site presents the company as a fully integrated CDMO serving programs from gene development through cGMP drug substance and drug product manufacturing. It also spotlights the ModularCMC platform, which uses AI/ML, standardized work packages, and Quality-by-Design methods to streamline CMC execution for antibody-based therapeutics. The updated site gives biotechnology customers clearer information on services, facilities, and partnership options, making it easier to evaluate Wheeler Bio as a development and manufacturing partner.

▦ Linked Companies